1. Home
  2. TPCS vs CGTX Comparison

TPCS vs CGTX Comparison

Compare TPCS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechPrecision Corporation

TPCS

TechPrecision Corporation

N/A

Current Price

$4.50

Market Cap

40.9M

Sector

Industrials

ML Signal

N/A

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

N/A

Current Price

$1.49

Market Cap

158.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TPCS
CGTX
Founded
1956
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.9M
158.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TPCS
CGTX
Price
$4.50
$1.49
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.88
AVG Volume (30 Days)
36.3K
953.6K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,564,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.15
N/A
52 Week Low
$2.05
$0.22
52 Week High
$6.25
$3.83

Technical Indicators

Market Signals
Indicator
TPCS
CGTX
Relative Strength Index (RSI) 54.58 42.84
Support Level $4.26 $1.69
Resistance Level $4.68 $1.76
Average True Range (ATR) 0.23 0.11
MACD 0.03 -0.02
Stochastic Oscillator 92.75 4.08

Price Performance

Historical Comparison
TPCS
CGTX

About TPCS TechPrecision Corporation

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: